W. Nicholson Price II
UNH School of Law
Nicholson Price is an Assistant Professor at the University of New Hampshire School of Law, where he researches and teaches on intellectual property, innovation policy, and the life sciences. In his time at the Petrie-Flom Center, Nicholson studied innovation in the pharmaceutical industry, personalized medicine, and the issues surrounding secondary findings in genomic research. His sole-author works from his time at the Center will be published in the Boston College Law Review, IP Theory, the New England Journal of Medicine, and the American Journal of Bioethics; co-authored pieces have appeared or will appear in Pediatrics, the Hastings Center Report, and Genetics in Medicine. He has given invited presentations at Harvard Law School, Yale Law School, Mass. General, and the National Institute for Pharmaceutical Technology and Education. This spring he is teaching an HLS seminar on Genetics and the Law.
Nicholson received his J.D. from Columbia Law School in 2011, where he was a James Kent Scholar, was Submissions Editor of the Columbia Science and Technology Law Review, and twice received the Julius Silver Note Prize. He received his Ph.D. in Biological Sciences, also from Columbia University, in 2010. He holds an A.B. in Biological Sciences from Harvard College. After law school, he clerked for Judge Carlos T. Bea of the U.S. Court of Appeals for the Ninth Circuit, and was a Visiting Consortium Scholar at the UCSF/UC Hastings Consortium on Law, Science and Health Policy. Nicholson’s scholarship focuses on innovation in the life sciences, including the influences of patent law, trade secrecy, and regulatory exclusivity on the drug industry, genetic testing, and personalized medicine. In Fall 2014 he will join the University of New Hampshire School of Law (formerly Franklin Pearce Law Center) as an Assistant Professor.
Patent Trolling—Why Bio & Pharmaceuticals Are at Risk, 17 Stan. Tech. L. Rev. __ (forthcoming 2014) (with Robin Feldman).
Generic Entry Jujitsu: Innovation and Quality in Drug Manufacturing, 3 IP Theory __ (forthcoming 2014).
Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing, 55 B.C. L. Rev. 491 (2014).
Does Whole-Genome Sequencing Circumvent Gene Patents? Bio-IT World (December 10, 2012).
Unblocked Future: Why Gene Patents Won’t Hinder Whole-Genome Sequencing and Personalized Medicine, 33 Cardozo L. Rev. 1601 (2012).
Am I My Son? Human Clones and the Modern Family, 11 Colum. Sci. Tech. L. Rev. 118 (2010).
Patenting Race: The Problems of Ethnic Genetic Testing of Patents, 8 Colum. Sci. Tech. L. Rev. 119 (2007).
- Patents and the Pharmaceutical Development Process
- Genetics and Patent Law
- Informed Consent for Genetic Research
- Legal Regulation of the Scientific Research Process
- Conflicts of Interest in Research
J.D., Columbia University School of Law, May 2011
Kent Scholar, Charles Bathgate Beck Prize
Columbia Science and Technology Law Review Submissions Editor 2006-09
Ph.D. in Biological Sciences, Columbia University Graduate School of Arts and Sciences, May 2010
A.B. cum laude in Biological Sciences, Harvard College, June 2004
Harvard Ballroom Dance Team
Harvard University Choir
- 2011-12, Clerk for Judge Carlos T. Bea, U.S. Court of Appeals for the Ninth Circuit
- 2011-12, Visiting Consortium Scholar, UCSF/UC Hastings Consortium on Law, Science and Health Policy
- 2010, Summer Associate, Simpson Thacher & Bartlett, LLP
- 2006-09, Researcher, Laboratory of John Hunt, Columbia University
- 2005 and 2006, Summer Associate, Quinn Emanuel, LLP